November 18, 2016 - By Vivian Park · 0 Comments
The stock of VITALITY BIOPHARMA INCORPORATED (OTCMKTS:VBIO) registered an increase of 203.87% in short interest. VBIO’s total short interest was 55,000 shares in November as published by FINRA. Its up 203.87% from 18,100 shares, reported previously. With 422,300 shares average volume, it will take short sellers 0 days to cover their VBIO’s short positions. About 90,478 shares traded hands. Vitality Biopharma Inc (OTCMKTS:VBIO) has risen 78.75% since April 18, 2016 and is uptrending. It has outperformed by 74.32% the S&P500.
Vitality Biopharma, Inc., formerly Stevia First Corp., is engaged in the development of cannabinoid prodrug pharmaceuticals. The company has a market cap of $17.39 million. The Firm unlocks the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. It currently has negative earnings. The Company’s product pipeline includes cannabosides, VITA-100 and VITA-210.
Vitality Biopharma, Inc., formerly Stevia First Corp., incorporated on June 29, 2007, is engaged in the development of cannabinoid prodrug pharmaceuticals. The Firm unlocks the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. The Company’s product pipeline includes cannabosides, VITA-100 and VITA-210. Cannabosides are cannabinoid glycoside prodrugs. The Firm has produced approximately 25 cannabosides and has various applications that include composition of matter claims for prodrugs of cannabinoids, including THC, cannabidiol (CBD) and cannabidivarin (CBDV).
More notable recent Vitality Biopharma Inc (OTCMKTS:VBIO) news were published by: Finance.Yahoo.com which released: “Vitality Biopharma Name Change and Corporate Actions Receive Shareholder Approval” on July 19, 2016, also Finance.Yahoo.com with their article: “Vitality Biopharma Announces International Patent Filing for Cannabinoid …” published on November 09, 2016, Marketwired.com published: “Vitality Biopharma Announces Expansion of Prodrug Pharmaceutical Portfolio” on August 24, 2016. More interesting news about Vitality Biopharma Inc (OTCMKTS:VBIO) were released by: Marketwired.com and their article: “Vitality Biopharma Advances Cannabosides for Treatment of Inflammatory Bowel …” published on July 27, 2016 as well as Smallcapnetwork.com‘s news article titled: “Vitality Biopharma (VBIO) Widens Its Net” with publication date: November 16, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Vivian Park